Bronchiolitis Obliterans

Luis Angel; Arturo Homma; Stephanie M. Levine

doi:10.1055/s-2000-9846

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2000; 21(2): 0123-0134
DOI: 10.1055/s-2000-9846

Bronchiolitis Obliterans

Luis Angel, Arturo Homma, Stephanie M. Levine

Division of Pulmonary Diseases/Critical Care Medicine, Department of Medicine, The University of Texas Health Science Center at San Antonio and the South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division, San Antonio, Texas

Abstract

ABSTRACT

Bronchiolitis obliterans (BO) is a fibrotic lung disease involving the small conducting airways. BO may be classified by etiology and underlying disease or, more commonly, by histopathological pattern. The two major histopathological categories are (1) BO organizing pneumonia (BOOP) and proliferative bronchiolitis and (2) constrictive bronchiolitis. The former is often idiopathic in nature and may also be associated with connective tissue diseases and inhalation injury. Characteristic findings on chest imaging include alveolar infiltrates and ground glass opacities and pulmonary function tests (PFTs) usually reveal restrictive dysfunction. Constrictive bronchiolitis is associated with organ transplantation, infections, connective tissue diseases, inhalation injury, and drugs and may also have an idiopathic origin. The radiographic characteristic is a mosaic pattern on high-resolution computed tomography (HRCT) and PFTs most often reveal obstructive dysfunction. This article will attempt to review constrictive BO, including histopathology, clinical presentation, radiographic appearance, and physiological findings, for both idiopathic diseases, as well as specific clinical-associated entities.

KEYWORD

Bronchiolitis obliterans - constrictive bronchiolitis - lung transplantation - bone marrow transplantation - panbronchiolitis

Full Text

References

REFERENCES

1 Lange W. Ueber eine eigenthumliche Erkrankung der kleinen Bronchien und Bronchiolen (Bronchitis and Bronchiolitis obliterans). Dtsch Arch Klin Med . 1901; 342-364
2 King T E. Bronchiolitis. In: Schwarz MI, King TE, Jr (eds). Interstitial Lung Diseases. 3rd ed. Hamilton, Canada: BC Decker 1998: 645-684
3 Guerry-Force M, Muller N L, Wright J L. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia and small airways disease. Am Rev Respir Dis . 1987; 135 705-712
4 King T E. Overview of bronchiolitis. Clin Chest Med . 1993; 14 607-610
5 Wright J, Cagle P, Churg A, Colby T V, Myers J. Diseases of the small airways. Am Rev Respir Dis . 1992; 146 240-262
6 Colby T V. Bronchiolar pathology. In: Epler GR, ed. Diseases of the Bronchioles New York: Raven Press, 1994: 77-100
7 Muller N L, Staples C A, Miller R R. Bronchiolitis obliterans organizing pneumonia. CT features in 14 patients. AJR Am J Roentgenol . 1990; 154 983-987
8 Colby T V. Bronchiolitis: Pathologic considerations. Am J Clin Pathol . 1998; 109 101-109
9 Colby T V, Myers J L. The clinical and histologic spectrum of bronchiolitis obliterans including bronchiolitis obliterans organizing pneumonia (BOOP). Semin Respir Med . 1992; 13 119
10 Lynch D A. Imaging of small airways disease. Clin Chest Med . 1993; 14 623-634
11 Worthy S A, Muller N L. Small airways diseases. Radiol Clin North Am . 1998; 36 163-173
12 Muller N L, Miller R R. Diseases of the bronchioles: CT and histopathologic findings. State of the art review. Radiology . 1995; 196 3-12
13 Hwang J, Rim T S, Lee K S. Bronchiolitis in adults: Pathology and Imaging. J Comput Assist Tomogr . 1997; 21 913-919
14 Lentz D, Bergin C J, Berry G J, Stoehr C, Theodore J. Diagnosis of bronchiolitis obliterans in heart-lung transplantation patients. Importance of bronchial dilatation on CT. Am J Radiol . 1992; 59 463-467
15 Turton C W, William G, Green M. Cryptogenic obliterative bronchiolitis in adults. Thorax . 1981; 36 805-810
16 Dorinsky P M, Davis W B, Lucas J G, Weiland J E, Gadek J E. Adult bronchiolitis. Evaluation by bronchoalveolar lavage and response to prednisone therapy. Chest . 1985; 88 58-63
17 Kindt G C, Weiland J E, Davis W B, Gadek J E, Dorinsky P M. Bronchiolitis in adults. A reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis . 1989; 140 483-492
18 St. John C R, Dorinsky P M. Cryptogenic bronchiolitis. Clin Chest Med . 1993; 14 667-675
19 Kraft M, Mortenson R L, Colby T V, Newman L, Waldron Jr A J, King Jr E T. Cryptogenic constrictive bronchiolitis. Am Rev Respir Dis . 1993; 148 1093-1011
20 Fitzgerald J E, King Jr E T, Lynch D A, Tuder R M, Schwarz M I. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med . 1996; 154 497-503
21 Tsang K WT, Ooi C GC, Ip M SM. Clinical profiles of Chinese patients with diffuse panbronchiolitis. Thorax . 1998; 53 274-280
22 Park M H, Kim Y W, Yoon H I. Association of HLA class I antigens with diffuse panbronchiolitis in Korean patients. Am J Respir Crit Care Med . 1999; 159 526-529
23 Sugiyama Y, Kudoh S, Maeda H, Suzaki H, Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis . 1990; 141 1459-1462
24 Homma H, Yamanaka A, Tanimoto S. Diffuse panbronchiolitis. A disease of the transitional zone of the lung. Chest . 1983; 83 63-69
25 Sugiyama Y. Diffuse panbronchiolitis. Clin Chest Med . 1993; 14 765-772
26 Homma S, Kawabata M, Kishi K. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J . 1998; 12 444-452
27 Kudoh S, Azuma A, Yamamoti M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med . 1998; 157 1829-1832
28 Ichikawa Y, Hotta M, Sumita S, Fujimoto K, Oizumi K. Reversible airway lesions in diffuse panbronchiolitis: Detection by high-resolution computed tomography. Chest . 1995; 107 120-125
29 Koyama H, Geddes DM: Erythromycin and diffuse panbronchiolitis. Thorax . 1997; 52 915-918
30 Kadota J-I, Sakito O, Kohno S. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis . 1993; 147 153-159
31 Commins B T, Raveney F J, Jesson M W. Toxic gases in tower silos. Ann Occup Hyg . 1971; 14 275
32 Horvath E P, do Pico A G, Barbee R A, Dickie H A. Nitrogen dioxide-induced pulmonary disease. J Occup Med . 1978; 20 103-110
33 Fleming G M, Chester E H, Montenegro H D. Dysfunction of small airways following pulmonary injury due to nitrogen dioxide. Chest . 1979; 75 720-721
34 Zwemer F L, Pratt D S, May J J. Silo filler's disease in New York State. Am Rev Respir Dis . 1992; 146 650-653
35 Douglas W W, Colby T V. Fume-related bronchiolitis obliterans. In: Epler GR, ed. Diseases of the Bronchioles New York: Raven Press, 1994: 187-213
36 Milne J EH. Nitrogen dioxide inhalation and bronchiolitis obliterans. J Occup Med . 1969; 11 538-547
37 Moskowitz R L, Lyons H A, Cottle H R. Silo-filler's disease: Clinical, physiologic and pathologic study of patient. Am J Med . 1964; 36 457-462
38 Becklake M R, Goldman H I, Bosman A R. The long-term effects of exposure to nitrous fumes. Am Rev Tuberc . 1957; 76 398-409
39 Ramirez R J, Dowell A R. Silo-filler's disease: Nitrogen dioxide-induced lung injury: long-term follow-up and review of the literature. Ann Intern Med . 1971; 74 569-576
40 Jones G R, Proudfoot A T, Hall J I. Pulmonary effects of acute exposure to nitrous fumes. Thorax . 1973; 28 61-65
41 Douglas W W, Norman G, Hepper G, Colby T V. Silo-filler's disease. Mayo Clin Proc . 1989; 64 291-304
42 Wells A U, du Bois M R. Bronchiolitis in association with connective tissue disorders. Clin Chest Med . 1993; 14 655-666
43 Epler G, Colby T, McLoud T, Carrington C B, Gaensler E A. Bronchiolitis obliterans organizing pneumonia. N Engl J Med . 1985; 312 152-158
44 Katzenstein A-L, Myers J, Prophet W, Corley III S L, Shin M S. Bronchiolitis obliterans an usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol . 1986; 10 373-38
45 Rees J H, Woodhead M A, Sheppard M M, du Bois M R. Rheumatoid arthritis and cryptogenic organizing pneumonia. Respir Med . 1991; 29 1582-1590
46 Yousem S A, Colby T V, Carrington C B. Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis . 1985; 131 770-777
47 Epler G R, Snider G L, Gaensler E A, Cathcart E S, FitzGerald M X, Carrington C B. Bronchiolitis and bronchitis in connective tissue disease: A possible relationship to the use of penicillamine. JAMA . 1979; 242 528-532
48 Bégin R, Massé S, Cantin A, Menard H A, Bureau M A. Airway disease in a subset of nonsmoking rheumatoid patients: Characterization of the disease and evidence for an autoimmune pathogenesis. Am J Med . 1982; 72 743-750
49 Penny W J, Knight R K, Rees A M, Thomas A L, Smith A P. Obliterative bronchiolitis in rheumatoid arthritis. Ann Rheum Dis . 1982; 41 469-472
50 Van de Laar M F J A, Westermann C JJ, Wagenaar S S, Dinant H J. Beneficial effect of intravenous cyclophosphamide and oral prednisolone on d-penicillamine-associated bronchiolitis obliterans. Arthritis Rheum . 1985; 28 93-97
51 Van Thiel J R, van der Burg S, Groote A D, Nossent G D, Wills S H. Bronchiolitis obliterans organizing pneumonia and rheumatoid arthritis. Eur Respir J . 1991; 4 905-911
52 Fortoul T I, Cano-Valle F, Oliva E, Barrios E. Follicular bronchiolitis in association with connective tissue diseases. Lung . 1985; 163 305-314
53 Yousem S A, Colby T V, Carrington C B. Follicular bronchitis/bronchiolitis. Hum Pathol . 1985; 16 700-706
54 Bjerke R D, Tashkin D P, Clements P J. Small airways in progressive systemic sclerosis (PSS). Am J Med . 1979; 66 201-209
55 Weaver A L, Divertie M B, Titus J L. Pulmonary scleroderma. Dis Chest . 1968; 54 4-12
56 Davison A G, Epstein D. Relapsing organizing pneumonitis in a man with primary biliary cirrhosis, CREST syndrome, and chronic pancreatitis. Thorax . 1983; 38 316-317
57 Min J K, Hong Y S, Park S H. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol . 1997; 24 2254-2257
58 Otsuka F, Amano T, Hashimoto N, Ogura T, Ishikawa A, Takahashi T. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus with antiphospholipid antibody. Intern Med . 1996; 35 341-344
59 Tazelaar H D, Viggiano R W, Pickersgill J. Interstitial lung disease in polymyositis and dermatomyositis: Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis . 1990; 141 727-733
60 Imasaki T, Yoshii A, Tanaka S. Polymyositis and Sjogren's syndrome associated with bronchiolitis obliterans organizing pneumonia. Intern Med . 1996; 35 231-235
61 Knoell K A, Hook M, Grice D P, Hendrix Jr D J. Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). J Am Acad Dermatol . 1999; 40 328-330
62 Akira M, Hara H, Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: Long-term follow-up CT evaluation in seven patients. Radiology . 1999; 210 333-338
63 Smith C B, Overall C JJ. Clinical and epidemiological clues to the diagnosis of respiratory infections. Radiol Clin North Am . 1973; 11 261-278
64 Penn C C, Liu C. Bronchiolitis following infection in adults and children. Clin Chest Med . 1993; 14 645-654
65 Philit F, Wiesendanger T, Archimbaud E, Mornex J-F, Brune J, Cordier J-F. Post-transplant obstructive lung disease (``bronchiolitis obliterans''): A clinical comparative study of bone marrrow and lung transplant patients. Eur Respir J . 1995; 8 551-558
66 Clark J G, Crawford S W, Madtes D K, Sullivan K M. Obstructive lung disease after allogeneic marrow transplantation: Clinical presentation and course. Ann Intern Med . 1989; 111 368-376
67 Palmas A, Tefferi A, Myers J L. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol . 1998; 100 680-687
68 Paz H L, Crilley P, Pachefsky A, Schiffman R L, Brodsky I. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest . 1992; 101 775-778
69 Clark J G, Schwartz D A, Flournoy N, Sullivan K M, Crawford S W, Thomas E D. Risk factors for airflow obstruction in recipients of bone marrow transplants. Ann Intern Med . 1987; 107 648-656
70 Prince D S, Wingard J R, Saral R, Santos G W, Wise R A. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest . 1989; 96 301-306
71 Crawford S W, Clark J G. Bronchiolitis associated with bone marrow transplantation. Clin Chest Med . 1993; 14 741-750
72 Yousem S A. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol . 1995; 26 668-675
73 Thirman M J, Devine S M, O'Toole K. Bronchiolitis obliterans organizing pneumonia as a complication of allogeneic bone marrow transplantation. Bone Marrow Transplant . 1992; 10 307-311
74 Quabeck K. The lung as a critical organ in marrow transplantation. Bone Marrow Transplant . 1994; 14 S19-S28
75 Calhoon J H, Levine S, Anzueto A, Bryan C L, Trinkle J K. Lung transplantation in a patient with a prior bone marrow transplant. Chest . 1992; 102 948
76 Hosenpud J D, Bennett L E, Keck B M, Fiol B, Boucek M M, Novick R J. The registry of the International Society for Heart and Lung Transplantation: Fifteenth official report-1998. J Heart Lung Transplant . 1998; 17 656-668
77 Trulock E P. Lung transplantation. Am J Respir Crit Care Med . 1997; 155 789-819
78 Kroshus T J, Kshettry V R, Savik K. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg . 1997; 114 195-202
79 Bando K, Paradis I L, Similo S. Obliterative bronchiolitis after lung and heart-lung transplantation: An analysis of risk factors and management. J Thorac Cardiovasc Surg . 1995; 110 4-14
80 Scott J P, Higgenbottam T W, Sharples L. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation . 1991; 51 813-817
81 Bando K, Paradis I L, Similo S. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J Thorac Cardiovasc Surg . 1995; 110 4-14
82 Husain A N, Siddiqui M T, Holmea E W. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med . 1999; 159 829-833
83 Sundaresan S, Mohanakumar T, Smith M A. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation . 1998; 65 648-653
84 Girgis R E, Tu I, Berry G J. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant . 1996; 15 1200-1208
85 Ross D J, Marchevsky A, Kramer M, Kass R M. ``Refractoriness'' of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J Heart Lung Transplant . 1997; 16 832-838
86 Schulman L L, Weinberg A D, McGregor C, Galantowicz M E, Suciu-Foca N M, Itescu S. Mismatches at the GLA-DR and GLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med . 1998; 157 1833-1837
87 Sundaresan R S, Trulock E P, Mohanakumar T, Cooper J D, Patterson G A, Washington Universisty Lung Transplant Group. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg . 1995; 60 1341-1347
88 Keller C A, Cagle P T, Brown R W, Noon G, Frost A E. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest . 1995; 107 973-980
89 Patterson G M, Wilson S, Whang J L. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: A comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant . 1996; 15 175-181
90 Ikonen T, Kivisaari L, Taskinen E, Piilonen A, Harjula A LJ. High-resolution CT in long-term follow-up after lung transplantation. Chest . 1997; 111 370-376
91 Leung A n, Fisher K, Valentine V. Bronchiolitis obliterans after lung transplantation. Chest . 1998; 113 365-370
92 International Society of Heart and Lung Transplantation, Cooper J D, Billlingham M. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant . 1993; 12 713-716
93 Ross D J, Lewis M I, Kramer M, Vo A, Kass R M. FK 506 `Rescue' immunosuppression for obliterative bronchiolitis after lung transplantation. Chest . 1997; 112 1175-1183
94 Kesten S, Chaparro C, Scavuzza M, Gutierrez C. Tacrolimus as rescue therapy for bronchiolitis obliterans symdrome. J Heart Lung Transplant . 1997; 16 905-912
95 Whyte R I, Rossi S J, Mulligan M S. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg . 1997; 64 945-948
96 Keenan R J, Konishi H, Kawai A. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg . 1995; 60 580-585
97 Date H, Lynch J P, Sundaresan S, Patterson G A, Trulock E P. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. J Heart Lung Transplant . 1998; 17 869-875
98 Valentine V G, Robbins R C, Berry G J. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant . 1996; 15 371-383
99 Katzenstein A-L, Myers J L. Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med . 1998; 157 1301-1315
100 Myers J L, Veal C F, Shin M S, Katzenstein A-L. Respiratory bronchiolitis causing interstitial lung disease: A clinicopathologic study of six cases. Am Rev Respir Dis . 1987; 135 880-884
101 Yousem S A, Colby T V, Gaensler E A. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc . 1989; 64 1373-1380